c-Myc tag Peptide (A6003): Mechanistic Uses in Immunoassays & Cancer Biology

Executive Summary: The c-Myc tag Peptide is a synthetic peptide corresponding to amino acids 410-419 of human c-Myc, used to competitively inhibit anti-c-Myc antibody binding in immunoassays (APExBIO). It is highly soluble in DMSO (≥60.17 mg/mL) and water with sonication (≥15.7 mg/mL), but insoluble in ethanol under standard laboratory conditions. c-Myc is a proto-oncogene encoding a key transcription factor for cell proliferation, apoptosis, and differentiation; its dysregulation is implicated in diverse cancers (Wu et al., 2021). The peptide is intended solely for research purposes and not for diagnostic or therapeutic use. Specific storage at -20°C in desiccated conditions is required to maintain peptide integrity (APExBIO).

Biological Rationale

The c-Myc proto-oncogene encodes a transcription factor (Myc) pivotal in regulating genes linked to cell cycle progression, growth, apoptosis, and stem cell maintenance (Wu et al., 2021). In physiological conditions, c-Myc modulates cyclin expression, promotes ribosomal biogenesis, and downregulates cell cycle inhibitors such as p21. Dysregulation, via gene amplification or enhanced stability, drives oncogenic transformation and is frequently observed in carcinomas and lymphomas. Synthetic c-Myc tag peptides, such as A6003, serve as essential tools in dissecting these regulatory networks by enabling controlled immunoassay displacement experiments (see mechanistic insights). This article extends those insights with detailed solubility, storage, and competitive binding data for experimental reproducibility.

Mechanism of Action of c-Myc tag Peptide

The c-Myc tag Peptide (A6003) is a synthetic decapeptide (sequence: EQKLISEEDL) that mimics the C-terminal region of human c-Myc (residues 410-419). In immunoassay workflows, the peptide acts as a competitive inhibitor by binding to anti-c-Myc antibodies, thereby displacing c-Myc-tagged fusion proteins or antigens. This mechanism allows for elution or verification of specific antibody-antigen interactions in Western blotting, immunoprecipitation, and ELISA assays (APExBIO). The high specificity of the peptide-antibody interaction underpins its utility in systems where accurate quantitation or removal of tagged proteins is critical. Notably, the peptide does not interact with unrelated antibody epitopes, minimizing assay background (see advanced troubleshooting strategies—this article explicitly details solubility and storage not previously covered).

Evidence & Benchmarks

• The c-Myc tag Peptide inhibits anti-c-Myc antibody binding to fusion proteins in a dose-dependent manner under standard immunoprecipitation buffer conditions (APExBIO product data: product page).
• c-Myc protein regulates transcription by dimerizing with Max and binding E-box DNA motifs, promoting cyclin and ribosomal gene expression and suppressing cell cycle inhibitor p21 (Wu et al., 2021, DOI).
• Peptide is soluble in DMSO ≥60.17 mg/mL at room temperature and in water ≥15.7 mg/mL with ultrasonic treatment, but insoluble in ethanol (APExBIO specs: product).
• Storage at -20°C under desiccation preserves peptide stability for ≥12 months; reconstituted solutions should be used immediately to prevent degradation (APExBIO data: product).
• Selective autophagy regulates transcription factor stability (e.g., IRF3) through ubiquitin-mediated degradation, a mechanism relevant by analogy to c-Myc turnover (Wu et al., 2021, DOI).

Applications, Limits & Misconceptions

The c-Myc tag Peptide is primarily used to elute or competitively block c-Myc-tagged proteins from antibody complexes, enabling high-specificity immunoprecipitation controls and efficient Western blot validation. It is also leveraged in studies of transcription factor regulation, cell proliferation, and apoptosis, especially in cancer research contexts where c-Myc function is dysregulated (see analysis of proto-oncogene function; this article updates solubility and workflow parameters not detailed elsewhere). However, the peptide is not suitable for diagnostic or therapeutic applications, nor does it modulate endogenous c-Myc function in live cells. Misconceptions often arise regarding its specificity and storage; see below:

Common Pitfalls or Misconceptions

• The c-Myc tag Peptide does not inhibit unrelated antibody-antigen interactions; it is specific to anti-c-Myc antibodies.
• It cannot be used to modulate endogenous c-Myc activity in living cells, as it functions solely as a competitive reagent in vitro.
• Long-term storage of reconstituted solution (even at -20°C) leads to degradation; only lyophilized peptide is stable for ≥12 months.
• Solubility in ethanol is negligible; use only DMSO or water (with sonication) for preparation.
• The product is for research use only and not validated for diagnostic or clinical applications.

Workflow Integration & Parameters

To integrate the c-Myc tag Peptide (A6003) into laboratory workflows, dissolve the lyophilized peptide in DMSO (≥60.17 mg/mL) or water with ultrasonic agitation (≥15.7 mg/mL). For immunoprecipitation elution, add a molar excess of peptide relative to the antibody binding capacity and incubate according to assay protocol. Store unused lyophilized peptide at -20°C in a desiccator. Avoid freeze-thaw cycles of reconstituted solutions to maintain activity (APExBIO). For detailed protocol optimization and scenario-based guidance, see five laboratory scenarios; this article provides expanded solubility and stability data beyond protocol design alone.

Conclusion & Outlook

The c-Myc tag Peptide (A6003) from APExBIO is a validated research reagent for the competitive displacement of c-Myc-tagged proteins and assay controls in molecular and cancer biology. Its robust solubility, defined specificity, and storage stability underpin reproducible assay performance. As research advances in transcription factor regulation and selective autophagy, precise reagents such as A6003 will remain essential for dissecting oncogenic signaling and refining immunoassay workflows (product page). For further mechanistic context or translational research applications, see our discussion on autophagy-driven transcription factor control; this article clarifies the experimental parameters and boundaries of c-Myc tag Peptide usage.